Your search returned 13 results.

Results
	1.	Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects. [electronic resource] by Iitsuka, Hiromi van Gelderen, Marcel Katashima, Masataka Takusagawa, Shin Sawamoto, Taiji Producer: 20160405 In: Clinical therapeutics vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	An Exploratory Study in Healthy Male Subjects of the Mechanism of Mirabegron-Induced Cardiovascular Effects. [electronic resource] by van Gelderen, Marcel Stölzel, Matthias Meijer, John Kerbusch, Virginie Collins, Christiane Korstanje, Cees Producer: 20180629 In: Journal of clinical pharmacology vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	An example of optimal phase II design for exposure response modelling. [electronic resource] by Maloney, Alan Schaddelee, Marloes Freijer, Jan Krauwinkel, Walter van Gelderen, Marcel Jacqmin, Philippe Simonsson, Ulrika S H Producer: 20110126 In: Journal of pharmacokinetics and pharmacodynamics vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Absence of clinically relevant cardiovascular interaction upon add-on of mirabegron or tamsulosin to an established tamsulosin or mirabegron treatment in healthy middle-aged to elderly men. [electronic resource] by van Gelderen, Marcel Tretter, Reiner Meijer, John Dorrepaal, Caroline Gangaram-Panday, Shanti Brooks, Ashley Krauwinkel, Walter Dickinson, James Producer: 20140925 In: International journal of clinical pharmacology and therapeutics vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol. [electronic resource] by Krauwinkel, Walter Dickinson, James Schaddelee, Marloes Meijer, John Tretter, Reiner van de Wetering, Jeroen Strabach, Gregory van Gelderen, Marcel Producer: 20140703 In: European journal of drug metabolism and pharmacokinetics vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives. [electronic resource] by Groen-Wijnberg, Monique van Dijk, Jan Krauwinkel, Walter Kerbusch, Virginie Meijer, John Tretter, Reiner Zhang, Wenhui van Gelderen, Marcel Producer: 20180226 In: European journal of drug metabolism and pharmacokinetics vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults. [electronic resource] by Lee, Jennifer Zhang, Wenhui Moy, Selina Kowalski, Donna Kerbusch, Virginie van Gelderen, Marcel Sawamoto, Taiji Grunenberg, Nicole Keirns, James Producer: 20130829 In: Clinical therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies. [electronic resource] by Iitsuka, Hiromi Tokuno, Tomoaki Amada, Yoko Matsushima, Hiroshi Katashima, Masataka Sawamoto, Taiji Takusagawa, Shin van Gelderen, Marcel Tanaka, Takanori Miyahara, Hideo Producer: 20150112 In: Clinical drug investigation vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women. [electronic resource] by Krauwinkel, Walter van Dijk, Jan Schaddelee, Marloes Eltink, Charlotte Meijer, John Strabach, Grégory van Marle, Sjoerd Kerbusch, Virginie van Gelderen, Marcel Producer: 20130322 In: Clinical therapeutics vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a β3-adrenoceptor agonist. [electronic resource] by Lee, Jennifer Moy, Selina Meijer, John Krauwinkel, Walter Sawamoto, Taiji Kerbusch, Virginie Kowalski, Donna Roy, Michael Marion, Alan Takusagawa, Shin van Gelderen, Marcel Keirns, James Producer: 20131227 In: Clinical drug investigation vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers. [electronic resource] by Takusagawa, Shin van Lier, Jan Jaap Suzuki, Katsuhiro Nagata, Masanori Meijer, John Krauwinkel, Walter Schaddelee, Marloes Sekiguchi, Mitsuhiro Miyashita, Aiji Iwatsubo, Takafumi van Gelderen, Marcel Usui, Takashi Producer: 20120803 In: Drug metabolism and disposition: the biological fate of chemicals vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron. [electronic resource] by Dickinson, James Lewand, Michaelene Sawamoto, Taiji Krauwinkel, Walter Schaddelee, Marloes Keirns, James Kerbusch, Virginie Moy, Selina Meijer, John Kowalski, Donna Morton, Richard Lasseter, Kenneth Riff, Dennis Kupčová, Viera van Gelderen, Marcel Producer: 20130702 In: Clinical drug investigation vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder. [electronic resource] by Eltink, Charlotte Lee, Jennifer Schaddelee, Marloes Zhang, Wenhui Kerbusch, Virginie Meijer, John van Marle, Sjoerd Grunenberg, Nicole Kowalski, Donna Drogendijk, Ted Moy, Selina Iitsuka, Hiromi van Gelderen, Marcel Matsushima, Hiroshi Sawamoto, Taiji Producer: 20121218 In: International journal of clinical pharmacology and therapeutics vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)